*Please note this programme is subject to change

Thursday 11th July 2019

08.00 – 08.45
     Gold sponsor industry symposia
                            Jock Colville Hall & Fellows’ Dining Hall                

09.00 – 09.15     Welcome                                                                  Wolfson Hall                                                                                                       

09.15 – 10.45     Precision cancer care
                           Chairs: Dr Li Tee Tan and Dr Helen Bolton, Cambridge

09.15 – 09.45    Ethical imperatives for precision medicine: A costly promise?
                           Prof Joshua Hordern, University of Oxford

09.45 – 10.15     “Value Based Health Care – the concept –
                            can it be applied to    gynaecological cancer?”
                            Professor John Moxham, Kings Healthcare Partnership

10.15 – 10.45    Precision medicine in gynaecological cancer
                          Dr Andrew Mortlock, Astra Zeneca

10.45 – 11.15    Coffee break and e-poster viewing                                                                         Marquee

11.15 – 12.15   New approaches for ovarian cancer treatment    Wolfson Hall

                         Chairs: Dr James Brenton and Professor Evis Sala, University of Cambridge     

11.15 – 11.45     Radiogenomics of ovarian cancer
                           Dr Ramona Woitek, University of Cambridge

11.45 – 12.15     Predicting response to treatment with multiparameter proteomic analysis in ovarian cancer
                           Dr Anniina Farkkila, University of Helsinki, Finland

12.15 – 12.30     Eulogy to Professor Martin Gore 1951-2019
                           Given by Professor John Shepherd, Trustee, BGCS

12.30 – 13.00     BGCS AGM

13.00 – 14.00     Lunch                                                                                                                                Dining Hall

13.00 – 14.00     Diamond sponsor industry symposium                                                                Jock Colville Hall
                            (Lunch will be served in the room)

14.00 – 14.30     Poster Workshop Presentations                                                                             Marquee

14.30 – 18.00     Main session: Latest news in gynaecological oncology trials, research and expert views                                       Wolfson Hall
                           Chairs: Mr Andy Nordin, Kent and Mr Krishnayan Haldar, Cambridge                    

14.30 – 14.50     Sentinel node techniques and their place in gynaecological oncology – update and view for BGCS meeting January 2019
                           Professor Christina Fotopoulou, Imperial College London

14.50 – 15.10     Follow up consensus meeting March 2019 BGCS
                           Dr Claire Newton, Bristol NHS Foundation/ Prof Sudha Sunda, University of Birmingham and President of BGCS

15.10 – 16.00     Oral presentations from selected abstracts
                           Chairs: Mr Peter Baldwin, Cambridge and Mr Phil Rolland,   Cheltenham (BGCS 2020)

15.10 – 15.20     O-1 Antitumour Activity and Updated Safety of the Poly(ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib as Monotherapy in Patients with Platinum-Sensitive, Relapsed, BRCA-Mutated, High-Grade Ovarian Cancer
                           Rebecca S. Kristeleit, UCL Cancer Institute, University College London and UCL Hospitals

 15.20 – 15.30     O-2 Effect of Maintenance Rucaparib on Postprogression Outcomes in Patients with Platinum-Sensitive, Recurrent Ovarian Carcinoma (OC) and Updated Safety Data from the Phase 3 Study ARIEL3
                           Andrew R. Clamp, The Christie NHS Foundation Trust and University of Manchester

 15.30 – 15.40     O-3 Randomised trial of unselected population based BRCA testing in Ashkenazi Jews: Long-term outcomes
Ranjit Manchanda, Barts Cancer Institute

15.40 – 15.50     O-4 Determining the Molecular Profile of Low Grade Serous Ovarian Carcinoma and its Association with Clinical Outcomes
                          Narthana Ilenkovan, University Of Sheffield

 15.50 – 16.00     O-5 Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)
                           Paul Stanciu, The Royal Marsden

16.00 – 16.30     Coffee break and e-poster viewing                                                                          Marquee

16.30 – 17.00     Oral presentations from selected abstracts

16.30 – 16.40     O-6 Machine learning & a novel patch sampling approach to generate biomarker cervicograms
                           Aslam Shiraz, Cambridge University Hospitals

16.40 – 16.50     O-7 UK perspectives from the Every Woman Study: comparing experiences of women being diagnosed and treated for ovarian cancer from around the world.
                           Frances Reid, The World Ovarian Cancer Coalition

16.50 – 17.00     O-8 Preliminary Safety, Efficacy, and Pharmacokinetic/Pharmacodynamic Characterization From GARNET, a Phase 1/2 Clinical Trial of the Anti–PD-1 Monoclonal Antibody Dostarlimab (TSR-042) in Patients With Recurrent or Advanced MSI-H and MSS Endometrial Cancer (EC)
                          Ana Oaknin, TESARO

17.00 – 17.30     Latest trial reports: surgical/medical oncology /radiation    oncology

17.00 – 17.10     Professor Christina Fotopoulou, Imperial College London –      surgery

17.10 – 17.20     Professor Iain McNeish, Imperial College London –        chemotherapy

17.20 – 17.30     Dr Alexandra Taylor, Royal Marsden Hospital London –            radiotherapy

17.30 – 18.00     NCRI Reports
                           Professor Iain McNeish, Moderator chair of NCRI

17.30 – 17.40     Presentation from the NCRI ovarian cancer group
                           Dr Shibani Nicum, Oxford Cancer Centre

17.40 – 17.50     Presentation from the NCRI endometrial cancer group
                           Dr Yvette Drew, Newcastle University

17.50 – 18.00     Presentation from the NCRI cervical cancer group
                           Dr Emma Hudson, Velindre Cancer Centre, Cardiff

14.30 – 18.00     Parallel session: Unit Leads  Jock Colville Hall
                            Chairs: Mr Partha Sengupta, Durham and Mr Tarang Majmudar, Cambridgeshire

14.30 – 15.00     HPV and what to do
                           Professor John Tidy, Sheffield Teaching Hospitals

15.00 – 15.30     Decision-making in oncology – an interactive session
                           Dr Li Tee Tan, Cambridge University Hospitals NHS Foundation Trust            

15.30 – 16.00     What to do with CA 125 and ovarian cysts
                            Mr Ketan Gajjar, Nottingham University Hospitals NHS Trust

16.00 – 16.30     Coffee break and e-poster  viewing                                                                        Marquee

16.30 – 17.00      Self Directed After Care (SDAC) for Low Risk Gynaecology  Cancer Patients – Experience of a Cancer Unit 
                            Eileen Murphy, Macmillan and Survivorship/eHNA Lead,   Hinchingbrooke Hospital and Mr Tarang Majmudar, Hinchingbrooke Hospital                        

 17.00 – 17.30    Issues for the unit lead and non centre working – a round  table discussion
                           Chaired by Mr Partha Sengupta, University Hospital of North Durham

18.00                 Close of day one

19.30 – 22.00     BGCS Annual Dinner at St John’s College


Friday 12th July 2019

08.00 – 08.45     Gold sponsor industry symposia
                            Jock Colville Hall & Fellows’ Dining Hall

09.10 – 09.15     Welcome                                 Wolfson Hall

09.15 – 10.45     Gynaecological Oncology – the patient and the doctor
                            Chairs: Dr Robin Crawford, Cambridge and Mr Ketan Gajjar,  Nottingham

09.15 – 09.45     Precision medicine and surgery – what’s true and what’s not?
                            Mr Mark Slack, Cambridge University Hospitals / CMR Surgical        

09.45 – 10.00     Philanthropic giving and fund raising
                           Mrs Gemma Downham, Addenbrookes Charitable Trust,      Cambridge

10.00 – 10.25     Consent and information provision
                           Mr Nigel Poole QC, Kings Chambers, Manchester

10.25 – 10.45      Burnout in oncology
                            Dr Susana Banerjee, Royal Marsden Hospital London

10.45 – 11.15     Coffee and e-poster viewing                                                                                      Marquee

11.15 – 11.35      Improving outcomes in older patients with gynaecological cancer
                            Dr Susana Banerjee and Dr Lucy Dumas, Royal Marsden   ospital London

11.35 – 12.00     Psychological Interventions in Gynaecological Cancer
                           Dr Ruaidhri McCormack and Dr Kathrin Hicks, Addenbrookes Hospital, Cambridge

12.00 – 13.00      Keynote lecture
                            Chair: Professor Evis Sala, Cambridge

                            Artificial intelligence and gynaecological oncology
                            Prof Mihaela van der Schaar, University of Cambridge

13.00 – 14.00     Lunch                                                                            Dining Hall                                                                    

13.00 – 14.00     Platinum sponsor industry symposium             Jock Colville Hall
                           (Lunch will be served in the room)

14.00 – 14.30     Poster Workshop Presentations                                                                             Marquee

14.30 – 17.20     Main session: Tomorrow’s world to the here and now                                      Wolfson Hall
                            Chairs: Mr John Latimer, Cambridge and Mr Ranjit            Manchanda, London   

14.30 – 15.00      What are we doing with the epidemic of endometrial                                           cancer? 
                            Professor Richard Edmondson, University of Manchester

15.00 – 15.20     New developments in hereditary ovarian tumours – genomic medicine comes to the fore
                           Dr Marc Tischkowitz, University of Cambridge

15.20 – 15.40     100,000 genome project – what is has shown us and where we are going in gynaecological oncology
                           Professor Clare Turnbull, Genomics England

15.40 – 16.00     Coffee break                                                                           
                            The Buttery

16.00 – 16.20     NCRAS nationwide data on cervical cancer surgery survival following laparoscopic radical hysterectomy and the ovarian cancer audit
                           Mr Andy Nordin, East Kent Gynaecological Oncology Centre and Past President of BGCS

16.20 – 17.20     Overview and discussion of where we are now – ovarian,    vulval, endometrial and cervical
                            Panel discussion on what should be offered in 2019 and what should be planned.  A Q&A session with audience participation.                                                       Panel members
                            Surgery: Andy Nordin Past President BGCS, Margate; Sudha Sundar President BGCS, Birmingham
                            Medical Oncology: James Brenton, Cambridge; Shibani           Nicum,Oxford
                            Radiation Oncology: Li Tee Tan, Cambridge; Alex Taylor,   London
                            Pathology: Naveena Singh, London
                            Radiology: Evis Sala, Cambridge

14.30 – 17.20     Parallel session: Nurse symposium                     Jock Colville Hall
                           Chairs: Helen Manderville, Gateshead and Ana Mendonca, Cambridge

14.30 – 15.00     Menopause, hormones and the cancer patient
                           Ms Debra Holloway, Nurse Consultant, Guys and St Thomas’  Hospital, London

15.00 – 15.30     Counselling and support taken to another level 
                           Dr Aneesh Shravat, Psychologist Maggie’s Cambridge

15.30 – 15.50     Coffee break                                                                           
                           The Buttery

15.50 – 17.20     Panel discussion: The role and future of the CNS in                 autonomous clinics
                           Chair: Helen Manderville, BGCS Nurse representative
                            Short presentations from:

15.50 – 16.00     Katie Bradshaw, Advanced practitioner in radiotherapy,

16.00 – 16.10     Sandra Beil, Surgical care practitioner, CUHNFT

16.10 – 16.20     Kate Maillou, CNS/colposcopist, CUHNFT

16.20 – 17.20     Panel discussion and audience Q&A

                            Panel members:
                            Helen Manderville, BGCS Nurse representative
                            Lorraine Szeremeta, Chief Nurse, Addenbrookes Cambridge
                            Tonia Dawson, MacMillan Clinical Lead, East of England  Cancer Alliance
                            Katie Bradshaw, Advanced practitioner in radiotherapy, CUHNFT
                            Sandra Beil, Surgical care practitioner, CUHNFT
                            Kate Maillou, CNS/colposcopist, CUHNFT

17.20 – 17.30     Presentation of prizes and close of conference                       Wolfson Hall
                           Prof Sudha Sundar, University of Birmingham and President of BGCS